GL

Garth Lees-Rolfe

Executive Officer

2 filings2 companiesActive Jun 4, 2024 — Jan 13, 2026

Companies

ABLi Therapeutics, Inc.

Executive Officer

1 filing

Last: Jan 13, 2026

Inhibikase Therapeutics, Inc.

1 filing

Last: Jun 4, 2024

Garth Lees-Rolfe — SEC Filing History | FilingFlow